CN1935157B - Medical stone emulsifiable paste for treating skin disease and its preparing method - Google Patents
Medical stone emulsifiable paste for treating skin disease and its preparing method Download PDFInfo
- Publication number
- CN1935157B CN1935157B CN200510106633A CN200510106633A CN1935157B CN 1935157 B CN1935157 B CN 1935157B CN 200510106633 A CN200510106633 A CN 200510106633A CN 200510106633 A CN200510106633 A CN 200510106633A CN 1935157 B CN1935157 B CN 1935157B
- Authority
- CN
- China
- Prior art keywords
- emulsifiable paste
- emulsion
- maifanitum
- powder
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a wheat-ball stone emulsifiable paste for curing dermatosis and its preparation method. Its raw material composition contains the components of wheat-ball stone, zine oxide, iron vitriol powder and liquefied phenol. It has obvious therapeutic effect for curing the diseases of psora, eczema, dermatitis and other subacute and chronic pruritic dermatosis.
Description
Technical field
The present invention relates to a kind of dermopathic medical stone emulsifiable paste and preparation method thereof that is used for the treatment of.
Background technology
Eczema, dermatitis and other itching skin disease are common human diseasess, often make the patient feel the pruritus discomfort.At present, the medicine that is used for the treatment of above-mentioned disease is a lot, and common have fluocinolone acetonide, PIKANG SHUANG etc. contain the medicine of hormones, are easy to generate side effect.
Scabies is the dermatosis that is caused by acaricide, often causes the patient skin damage, make patient's pruritus unbearably, and acaricide adopts general medicine to be difficult to kill, and certain degree of difficulty is arranged in the treatment.
Maifanitum is a rare stone in China's medical treasure-house.The holy Li Shizhen (1518-1593 A.D.) of Ming Dynasty's medicine is put down in writing in the monumental work Compendium of Material Medica: " the Maifanitum nature and flavor are sweet, and temperature is nontoxic, cures mainly all carbuncle carbuncle on the back, and skin ulcer is swollen to be tested invariably ".Maifanitum has the peculiar effect of preventing diseases and keeping fit, is called " long-lived stone ", " mineral spring YAOSHI " by common people.
The existing at present report that adopts Maifanitum as drug component treatment eczema for example, discloses a kind of cream for the treatment of infant eczema among the CN1050287C, comprised Maifanitum and diphenhydramine in its prescription.But this prescription does not have acaricidal action, is not suitable for being used for the treatment of diseases such as scabies.
Summary of the invention
The objective of the invention is to, a kind of emulsifiable paste that is used for the treatment of scabies, eczema, contact dermatitis and other itching skin disease is provided, this emulsifiable paste is to be principal agent with the Chinese medicine natural medical stone, and add an amount of Western medicine oxide powder and zinc and the mixed medical stone emulsifiable paste of making of emulsion-type emulsifiable paste matrix, above-mentioned illness is had notable therapeutic effect.
Another object of the present invention is to, described medicaments preparation method is provided.
A further object of the present invention is, provides described emulsifiable paste to be used for the treatment of the application of the medicament of scabies, eczema, contact dermatitis and other acute itching skin disease in preparation.
Specifically, the raw material of emulsifiable paste of the present invention by weight the composition of % meter be:
Maifanitum 30-50%, zinc oxide 10-15%, ferrosisuifas crudus 10-15%, liquefied phenol 0.5-3% and emulsion-type emulsifiable paste matrix %.Substrates quantity is added to 100%.
Preferably, in the emulsifiable paste of the present invention, the emulsifiable paste raw material composition of % meter by weight is:
Maifanitum 40%, zinc oxide 14%, ferrosisuifas crudus 12%, liquefied phenol 2% and emulsion-type emulsifiable paste matrix.Substrates quantity adds to 100%.
Emulsifiable paste of the present invention can adopt conventional method to be mixed and form, and preferably, adopts following steps:
The Maifanitum powder is crossed the 100-400 mesh sieve, be preferably fineness more than 300 orders, add oxidation zinc powder, ferrosisuifas crudus powder and an amount of emulsion-type emulsifiable paste matrix and mix well, the emulsion-type emulsifiable paste matrix that adds liquefied phenol and capacity is again mixed well once more.
Medicament of the present invention can adopt various conventional emulsion-type emulsifiable paste matrixes, also can adopt other emulsifiable paste matrix to substitute.
Emulsifiable paste of the present invention can be used for treating scabies, eczema, dermatitis, carbuncle sore, herpes, bee sting, decubital ulcer, folliculitis and other itching skin disease, especially subacute or chronic scabies.
Emulsifiable paste of the present invention can also be used to prepare the medicament of dermatopathies such as treatment scabies, eczema, dermatitis, carbuncle sore, herpes, bee sting, decubital ulcer, folliculitis as drug component.
Emulsifiable paste of the present invention dermatosis is had draw out the pus, antiinflammatory, analgesia, the convergence open sore part, external is coated with can treat scabies, eczema, dermatitis, carbuncle sore, herpes, bee sting, decubital ulcer, folliculitis and other itching skin disease.
Emulsifiable paste administering mode of the present invention is that usual manner is coated with usefulness outward.
Treatment is during scabies, emulsifiable paste of the present invention is coated with puts on the skin on skin, and the adult can put following all skins of cervical region on the skin, the baby puts on the skin all over whole skin, and put on the skin 3-5 time every day outward, puts 7 days medicines continuously on the skin, do not have a bath during the medication, had a bath, and changed the underwear pants of cleaning in the 8th day, exhausted underwear, underwear, coverlet, mat wash clean, hot water boils and scalded 30 minutes, to have killed acaricide and sarcoptic mite ovum, need not during the medication to take orally, the external other medicines are avoided irritable foods such as Fructus Capsici, wine.
Adopt emulsifiable paste clinical observation of the present invention not have obvious toxic and side effects, pollution-free, patient is willing to accept, and treats acute or chronic scabies, eczema, dermatitis, carbuncle sore, herpes, bee sting, decubital ulcer, folliculitis and other itching skin disease and can obtain significant curative effect.
With the treatment scabies is example, took a turn for the better in general medication 3-5 days, and recovery from illness after 7 days, patient's pruritus disappears.Get patient's skin lesion at the 9th day or the 10th day and make direct microscopy, can not find acaricide or sarcoptic mite ovum.
The specific embodiment
Hereinafter the mode with non-limiting examples provides optimal way of the invention process.
Embodiment 1
Get Maifanitum powder 40 and restrained 300 mesh sieves, add oxidation zinc powder 14 grams, ferrosisuifas crudus powder 12 grams and 10 gram emulsion-type emulsifiable paste matrixes and be developed into pasty state, add 2 milliliters of liquefied phenols again and add 22 gram emulsion-type emulsifiable paste matrixes, mix homogeneously promptly gets 100 grams emulsifiable paste of the present invention.
Embodiment 2
Get Maifanitum powder 45 and restrained 300 mesh sieves, add oxidation zinc powder 10 grams, ferrosisuifas crudus powder 10 grams and 10 gram emulsion-type emulsifiable paste matrixes and be developed into pasty state, add 2 milliliters of liquefied phenols and 23 gram emulsion-type emulsifiable paste matrixes again, mix homogeneously promptly gets 100 grams emulsifiable paste of the present invention.
Embodiment 3
Get Maifanitum powder 35 and restrained 300 mesh sieves, add oxidation zinc powder 12 grams, ferrosisuifas crudus powder 12 grams and 10 gram emulsion-type emulsifiable paste matrixes and be developed into pasty state, add 2 milliliters of liquefied phenols and 29 gram emulsion-type emulsifiable paste matrixes again, mix homogeneously promptly gets 100 grams emulsifiable paste of the present invention.
Medicament of the present invention has now been cured patient's 9018 examples through clinical use, and total effective rate reaches 100%, does not have local and whole body toxic and side effects during medication, owing to do not contain hormone, there is not the side effect of hormone knock-on sample in medication.
Those skilled in the art will know that; and do not depart under the situation of spirit of the present invention; can improve emulsifiable paste of the present invention; for example; be added into other routine at emulsifiable paste of the present invention and be used for the treatment of described dermopathic medicinal component; addition is deducted from substrates quantity, but does not influence flesh and blood of the present invention, and these improve all within the scope of protection of present invention.
Claims (5)
1. one kind is used for the treatment of dermopathic emulsifiable paste, and the raw material that it is characterized in that this emulsifiable paste composition of % meter by weight is: Maifanitum 30-50%, and zinc oxide 10-15%, ferrosisuifas crudus 10-15%, liquefied phenol 0.5-3% and emulsion-type emulsifiable paste matrix, substrates quantity adds to 100%.
2. emulsifiable paste according to claim 1, the raw material that it is characterized in that this emulsifiable paste composition of % meter by weight are: Maifanitum 40%, and zinc oxide 14%, ferrosisuifas crudus 12%, liquefied phenol 2% and emulsion-type emulsifiable paste matrix, substrates quantity adds to 100%.
3. the preparation method of claim 1 or 2 described emulsifiable pastes, it comprises the steps: the Maifanitum powder is crossed the 100-400 mesh sieve, add the oxidation zinc powder, ferrosisuifas crudus powder and an amount of emulsion-type emulsifiable paste matrix are mixed well, and the emulsion-type emulsifiable paste matrix that adds liquefied phenol and capacity is again mixed well once more.
4. claim 1, the application of 2 described emulsifiable pastes in the medicine of preparation treatment scabies, eczema, dermatitis, carbuncle sore, herpes, bee sting, decubital ulcer, folliculitis.
5. according to the application of claim 4, wherein: described emulsifiable paste is used to prepare the medicament for the treatment of subacute or chronic scabies.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200510106633A CN1935157B (en) | 2005-09-22 | 2005-09-22 | Medical stone emulsifiable paste for treating skin disease and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200510106633A CN1935157B (en) | 2005-09-22 | 2005-09-22 | Medical stone emulsifiable paste for treating skin disease and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1935157A CN1935157A (en) | 2007-03-28 |
| CN1935157B true CN1935157B (en) | 2010-05-05 |
Family
ID=37953017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200510106633A Expired - Fee Related CN1935157B (en) | 2005-09-22 | 2005-09-22 | Medical stone emulsifiable paste for treating skin disease and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1935157B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109157540A (en) * | 2018-11-21 | 2019-01-08 | 东南大学 | Application of the medical stone in preparation prevention and treatment anaphylactia, mental disorder, metabolism class disease and endocrine disturbance disease medicament |
| CN110123914B (en) * | 2019-06-03 | 2021-08-20 | 赣南医学院第二附属医院 | Compound medical stone ointment for treating intractable wound and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1513963A (en) * | 2002-12-31 | 2004-07-21 | 张少建 | Mud bath soap and its preparation method |
-
2005
- 2005-09-22 CN CN200510106633A patent/CN1935157B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1513963A (en) * | 2002-12-31 | 2004-07-21 | 张少建 | Mud bath soap and its preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 王苏新.麦饭石特性及作用分析.江苏陶瓷36 1.2003,36(1),1-2. |
| 王苏新.麦饭石特性及作用分析.江苏陶瓷36 1.2003,36(1),1-2. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1935157A (en) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1325083C (en) | Medicinal composition for removing dampness to relieve itching and its preparation method and uses | |
| CN104474076A (en) | Traditional Chinese medicine composition for treating eczema | |
| CN101810642B (en) | Chinese medicinal preparation for treating canker sores and acute tonsillitis and preparation method thereof | |
| CN100536901C (en) | Chinese medicine for treating burn, scald and frostbite | |
| CN103463284B (en) | Gynecological cleaning liquid and preparation method thereof | |
| CN1935157B (en) | Medical stone emulsifiable paste for treating skin disease and its preparing method | |
| CN105362491A (en) | External-use medicine for treating cervical vertebra hyperosteogeny | |
| CN1814201A (en) | Chinese-medicine cataplasma for treating cervical vertebra disease and preparing method | |
| CN100544761C (en) | A kind of medicine for the treatment of coronary heart disease | |
| CN106177725A (en) | A kind of treat the plaster compositions of mastopathy, purposes and preparation method thereof | |
| CN103356697A (en) | Stem cell preparation and oral fluid prepared therefrom | |
| CN115463200A (en) | Traditional Chinese medicine composition and patch for treating adenoidal hypertrophy and preparation method thereof | |
| CN108261487A (en) | A kind of analgesia Chinese medicine composition and its obtained analgesia ointment and pain easing plaster | |
| CN105125708B (en) | A kind of pharmaceutical composition and preparation method thereof for rhinitis | |
| CN104042811B (en) | Externally applied compound medicament for treating catabasis of bronchial asthma, preparation method and application thereof | |
| CN101239173B (en) | Externally-applied Chinese medicine for treating beriberi | |
| CN1057467C (en) | Medicine for treating impetigo | |
| CN109395050A (en) | Paediatrics external application massage the ointment formula, preparation method and application for treating diarrhea | |
| CN104857303A (en) | Preparation method of medicine for treating infantile eczema | |
| CN1775224A (en) | Medical stone lotion for treating skin disease and its preparing method | |
| CN110772627B (en) | Tibetan medicine rheumatism eliminating ointment and preparation method and application thereof | |
| CN104096170B (en) | External-use ultra-fine powder traditional Chinese medicine for weight loss and preparation method thereof | |
| CN102327300B (en) | External traditional Chinese medicine ointment for treating bone tuberculosis and lymphoid tuberculosis | |
| CN1569079A (en) | Externally applied medicament for treating mammary gland disease and its preparing method | |
| CN101721547A (en) | Medicine for treating onychomycosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100505 Termination date: 20130922 |